The Potential Antidepressant Compound Org 34167 Modulates HCN Channels Via a Novel Mode of Action

Area of Science:

• Neuroscience
• Molecular Pharmacology
• Biophysics

Background:

• Org 34167 is a small molecule modulator of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.
• HCN channels are implicated in neuronal excitability and have been targeted for antidepressant therapies.
• The precise mechanism of Org 34167's action on HCN channels remains unclear.

Purpose of the Study:

• To elucidate the molecular mechanism by which Org 34167 interacts with human HCN1 channels.
• To investigate the impact of Org 34167 on HCN1 channel gating kinetics and voltage dependence.
• To determine the specific domains of the HCN1 channel involved in Org 34167's modulation.

Main Methods:

• Two-electrode voltage clamp electrophysiology on heterologously expressed human HCN1 channels.
• Development and application of a 10-state allosteric gating model.
• Electrophysiological recordings on wild-type and truncated HCN1 channels (lacking C-terminal nucleotide binding domain).

Main Results:

• Org 34167 induced a hyperpolarizing shift in HCN1 channel activation and slowed activation kinetics.
• A voltage-independent mechanism contributed to reduced maximum open probability.
• Allosteric modeling indicated Org 34167 reduces pore domain equilibrium, impairs voltage-sensing/pore-domain coupling, and favors the inactive state of the voltage-sensing domain.
• Org 34167's effects were observed even without the C-terminal nucleotide binding domain.

Conclusions:

• Org 34167 inhibits human HCN1 channel activity through complex modulation of multiple channel domains.
• The drug affects voltage-dependent gating, activation kinetics, and interdomain communication.
• Findings provide mechanistic insight into Org 34167's potential antidepressant effects mediated by HCN channel inhibition.